Status:
COMPLETED
Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Eisai Inc.
Conditions:
Dementia Associated With Cerebrovascular Disease
Eligibility:
All Genders
45+ years
Phase:
PHASE3
Brief Summary
one year extension study following a previous double-blind study to evaluate safety of the drug
Detailed Description
A one year extension study for patients who completed E2020-A001-319. Patients will receive 5my donepezil daily for the first 8 weeks and will be assessed by the incidence of advere events, changes in...
Eligibility Criteria
Inclusion
- must have completed previous study E2020-A001-319
Exclusion
- absence of a reliable caregiver
- clinically significant medical condition
- recent TIA
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00188812
Start Date
May 1 2004
End Date
August 1 2005
Last Update
January 12 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hopital
Toronto, Ontario, Canada, M5T 2S8